Filing Details

Accession Number:
0001209191-13-045954
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-09-27 16:49:03
Reporting Period:
2013-09-25
Filing Date:
2013-09-27
Accepted Time:
2013-09-27 16:49:03
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1385228 Bind Therapeutics Inc BIND Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1548606 Rusnano 10A 60-Letiya Oktyabrya Prospect
Moscow 1Z 117036
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2013-09-25 1,053,291 $0.00 1,371,357 No 4 C Direct
Common Stock Acquisiton 2013-09-25 120,000 $15.00 1,491,357 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 C Direct
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Series D Preferred Stock Disposition 2013-09-25 2,759,624 $0.00 1,053,291 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 No 4 C Direct
Footnotes
  1. The convertible preferred stock is convertible at any time, at the holder's election, and has no expiration date. Immediately prior to closing of the issuer's initial public offering, the preferred stock held by the reporting person automatically converted into common stock on a 2.62 to 1 basis.